Showing results (121-130 of 240) with videos related to
Sort By:
Pageof 24
European Journal of Immunology|July 1, 1984
Low sialic acid-bearing mouse thymocytes do not express helper T cell properties in vitroL R Herron, J M Collins, C A Abel, et al.Cancer Drug Delivery|January 1, 1985
Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: comparison of intravenous, intramuscular, and intraventricular deliveryJ M Collins, R Riccardi, P Trown, et al.Clinical Pharmacology and Therapeutics|June 1, 1984
Cytosine arabinoside cerebrospinal fluid kineticsS Zimm, J M Collins, J Miser, et al.AJR. American Journal of Roentgenology|August 7, 1998
Meniscal cysts: detection with high-resolution sonographyM J Rutten, J M Collins, A van Kampen, et al.Blood Cells|January 1, 1980
Applications of light scatter to separation of stem cellsW M Grogan, J L Haar, R B Scott, et al.Cancer Treatment Reports|December 1, 1978
Improved therapeutic index of bleomycin when administered by continuous infusion in miceB I Sikic, J M Collins, E G Mimnaugh, et al.Antimicrobial Agents and Chemotherapy|May 1, 1997
Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazoleC B Trapnell, C Jamis-Dow, R W Klecker, et al.Plant Cell Reports|November 19, 2013
Recovery of primary transformants of soybeanW A Parrott, L M Hoffman, D F Hildebrand, et al.Journal of Neurovirology|December 22, 1999
Central nervous system chemokine expression during Theiler's virus-induced demyelinating diseaseL M Hoffman, B T Fife, W S Begolka, et al.Cancer Treatment Reports|January 1, 1986
Potential roles for preclinical pharmacology in phase I clinical trialsJ M Collins, D S Zaharko, R L Dedrick, et al.Pageof 24